Stromal Gene Expression During Pulmonary Sarcoidosis
Stopped early
Conditions studied: Sarcoidosis
In brief
to determine the genetic pathways operating at the tissue level to cause granulomatous inflammation in the lungs and lymph nodes of patients with sarcoidosis. By so doing, we hope to identify unique genetic mechanisms which will aid in the diagnosis of sarcoidosis and will help us understand the pathogenesis of this poorly understood disease.
Key facts
- Study ID
- NCT00837668
- Run by
- Ohio State University
- People needed
- 110
- Starts
- 2005-04-01
- Expected to finish
- 2012-02-01
- Last updated by the study team
- 2017-06-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- diagnosis of sarcoidosis
You may not qualify if…
- inability to provide consent
Where it is running
- The Ohio State University — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.